Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgi-associated RAB2 interactor protein 2 (GARIN2) is a member of the GARIN/FAM71 protein family, which consists of multiple related genes predominantly expressed in the testis[1][2][3]. GARIN2 and other GARIN family members possess a conserved RAB2-binding domain and can interact with RAB2A and RAB2B, small GTPases involved in membrane trafficking between the Golgi apparatus and other organelles in spermiogenesis[1][2]. In mice, knockout of GARIN2 leads to abnormal sperm head morphogenesis but does not significantly impair male fertility, indicating an important but not absolutely essential role in sperm development[1][2]. GARIN2 is predicted to participate in membrane vesicle transport and morphological maturation of sperm cells, alongside other related proteins. To date, there are no known drugs targeting this protein, and it is not recognized as a standard therapeutic target in human disease[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgi-associated RAB2 interactor protein 2 (GARIN2).